Overview

Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of HC-58 in patients with severe upper limb hemiplegia following stroke.
Phase:
Phase 2
Details
Lead Sponsor:
Asahi Kasei Pharma Corporation